We are live on ! Find out more
DLPIC

Davide Leone & Partners Investment Company Portfolio holdings

AUM $49M
1-Year Est. Return 43.06%
This Fund
S&P 500
This Quarter Est. Return
+23.94%
1 Year Est. Return
+43.06%
3 Year Est. Return
+64.09%
5 Year Est. Return
+180.81%
10 Year Est. Return
+512.91%
AUM
$779M
AUM Growth
+$222M
Cap. Flow
+$120M
Cap. Flow %
15.43%
Top 10 Hldgs %
84.43%
Holding
19
New
8
Increased
1
Reduced
1
Closed
4

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$91.3M
2
MDCO
Medicines Co
MDCO
+$76.4M
3
TIF
Tiffany & Co.
TIF
+$67.5M
4
HPQ icon
HP
HPQ
+$37.9M
5
QGEN icon
Qiagen
QGEN
+$35.4M

Top Sells

Rank Stock Value
1
AABA
Altaba Inc
AABA
+$106M
2
CELG
Celgene Corp
CELG
+$100M
3
S
Sprint Corporation
S
+$36.8M
4
BIIB icon
Biogen
BIIB
+$32.4M
5
BB icon
BlackBerry
BB
+$15.6M

Sector Composition

Rank Sector Weight
1 Healthcare 24.48%
2 Technology 11.76%
3 Communication Services 11.32%
4 Financials 0.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDCO
1
DELISTED
Medicines Co
MDCO
$97.4M 12.5%
+1,146,192
New +$76.4M
AGN
2
DELISTED
Allergan plc
AGN
$96.8M 12.42%
+506,100
New +$91.3M
T icon
3
AT&T
T
$163B
$88.2M 11.32%
2,987,382
MDCO
4
CALL
DELISTED
Medicines Co
MDCO
$84.9M 10.9%
+1,000,000
New +$66.7M
TIF
5
DELISTED
Tiffany & Co.
TIF
$76.4M 9.8%
+571,312
New +$67.5M
BB icon
6
BlackBerry
BB
$5.26B
$50.6M 6.49%
7,874,326
-2,845,566
-27% -$15.6M
ZAYO
7
DELISTED
Zayo Group Holdings, Inc.
ZAYO
$47.3M 6.07%
1,365,744
HPQ icon
8
HP
HPQ
$27.5B
$41.1M 5.28%
+2,000,000
New +$37.9M
HPQ icon
9
PUT
HP
HPQ
$27.5B
$41.1M 5.28%
+2,000,000
New +$37.9M
QGEN icon
10
Qiagen
QGEN
$8.72B
$34.1M 4.38%
+952,587
New +$35.4M
S
11
CALL
DELISTED
Sprint Corporation
S
$33.3M 4.28%
+6,396,700
New +$37.5M
INCY icon
12
Incyte
INCY
$24.4B
$32.6M 4.18%
373,387
VRTX icon
13
Vertex Pharmaceuticals
VRTX
$126B
$27.2M 3.49%
124,358
+47,800
+62% +$9.67M
BRK.A icon
14
Berkshire Hathaway Class A
BRK.A
$1.12T
$340K 0.04%
1
BIIB icon
15
Biogen
BIIB
$30.7B
-139,107
Closed -$32.4M
S
16
DELISTED
Sprint Corporation
S
-6,270,634
Closed -$36.8M
AABA
17
DELISTED
Altaba Inc
AABA
-5,446,180
Closed -$106M
CELG
18
DELISTED
Celgene Corp
CELG
-1,008,000
Closed -$100M

Similar funds

Davide Leone & Partners Investment Company's Q4 2019 Portfolio in Review

As of Q4 2019, Davide Leone & Partners Investment Company held 19 positions worth $779M, up 40% from $557M the previous quarter. Its ten largest holdings account for 84% of the portfolio.

Davide Leone & Partners Investment Company deployed $120M of net new capital in Q4 2019, opening 8 new positions and adding to 1 existing holding. Its largest new stake was Allergan plc: 506,100 shares worth $96.8M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 31% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was BlackBerry, an estimated $15.6M trimmed.

  • Davide Leone & Partners Investment Company's largest Q4 2019 buy was Allergan plc: 506,100 shares worth $96.8M.
  • Davide Leone & Partners Investment Company added most to Vertex Pharmaceuticals in Q4 2019, an estimated $9.67M increase.
  • Davide Leone & Partners Investment Company's biggest Q4 2019 reduction was BlackBerry, cutting an estimated $15.6M.
  • Davide Leone & Partners Investment Company fully exited Altaba Inc in Q4 2019, selling an estimated $106M.
  • Davide Leone & Partners Investment Company's ten largest holdings make up 84% of its $779M portfolio in Q4 2019.
  • Davide Leone & Partners Investment Company opened 8 new positions and closed 4 in Q4 2019.
  • Davide Leone & Partners Investment Company's portfolio value rose 40% quarter-over-quarter to $779M.

Based on Davide Leone & Partners Investment Company's 13F filing for Q4 2019, filed 14 Feb 2020.